A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Clinical trial NCT02757768 · COMPLETED
Trial details
- NCT number
- NCT02757768
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2018-08-14
- Enrollment
- 715
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.